CryoCloud, founded in 2021 and headquartered in The Netherlands, champions the intersection of Biotechnology, Cloud Infrastructure, and the Internet with its innovative cloud-native platform for cryo-EM data analysis. Their slogan, "Accelerating cryo-EM with our cloud-native data platform," accurately reflects the company's mission to democratize and streamline cryo-EM processes.
With no local hardware or complex software installations required, CryoCloud provides a seamless, intuitive experience for users, offering features like live data uploads and scalable cloud storage. It's designed to suit both newcomers and advanced structural biology labs, facilitating rapid end-to-end analysis.
In its latest funding round, CryoCloud secured a €2.00M seed investment on 01 May 2025, backed by investors such as Nina Ventures, Value Creation Capital, ROM Utrecht Region, and Utrecht Health Seed Fund. This investment highlights confidence in CryoCloud's potential to remove technical barriers and revolutionize cryo-EM data analysis.